Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

ATH/MEDIC stock hub

ATH/MEDIC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ATH/MEDICis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

11.3M

Athens Stock Exchange

Market data

Price

Recent price action with selectable time range.

ATH/MEDICATH/MEDIC

—

Loading chart…

In the news

Latest news · ATH/MEDIC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E6.1

P25 n/aP50 n/aP75 n/a

ROE9.6

P25 n/aP50 n/aP75 n/a

ROIC9.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ATH/MEDIC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

230

Groups with data

Currency

EUR

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Greece
Country code	GR
Employees	151
Enterprise value	EUR 12M
Exchange	Athens Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	GRS424003002
Last refreshed	2026-05-10
Market cap	EUR 11.3M
Price	EUR 2.56
Price currency	EUR
Rev Per Employee	122,782.17x
Sector	Healthcare
Sic	3845
Symbol	ath/MEDIC
Website	https://www.mediconsa.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	16.77%
EV Earnings	6.31x
EV/EBIT	5.39x
EV/EBITDA	3.13x
EV/FCF	31.96x
EV/Sales	0.65x
FCF yield	3.31%
P/B ratio	0.58x
P/E ratio	6.1x
P/S ratio	0.61x
PE Ratio10 Y	8.11x
PE Ratio3 Y	9.37x
PE Ratio5 Y	9.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.99%
EBITDA Margin	18.57%
FCF margin	2.02%
Gross margin	70.43%
Gross Profit	EUR 13.1M
Gross Profit Growth	1.37%
Gross Profit Growth Q	2.87%
Gross Profit Growth3 Y	0.1%
Gross Profit Growth5 Y	-3.35%
Net Income	EUR 1.9M
Net Income Growth	131.14%
Net Income Growth Q	202.22%
Net Income Growth3 Y	12.81%
Net Income Growth5 Y	-5.62%
Pretax Margin	11.74%
Profit Margin	10.23%
Profit Per Employee	EUR 12,565
ROA	4.31
Roa5y	5.65
ROCE	7.84
ROE	9.63
Roe5y	12.33
ROIC	9.29
Roic5y	11.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	17.97%
Cagr15y	2.44%
Cagr1y	21.45%
Cagr20y	0.3%
Cagr3y	-9.03%
Cagr5y	6.74%
Div CAGR10	1.4%
Div CAGR3	-5.31%
Div CAGR5	2.82%
EPS Growth	131.1
EPS Growth Q	202.2
EPS Growth3 Y	12.81
EPS Growth5 Y	-5.62
FCF Growth	-44.19%
FCF Growth Q	-58.61%
FCF Growth5 Y	-14.92%
OCF Growth	-42.9%
OCF Growth Q	-58.81%
OCF Growth10 Y	-5.05%
OCF Growth3 Y	9.84%
OCF Growth5 Y	-1.39%
Revenue Growth	6.6x
Revenue Growth Q	4.93x
Revenue Growth3 Y	0.77x
Revenue Growth5 Y	-2.25x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.58
Assets	EUR 32.4M
Cash	EUR 9M
Current Assets	EUR 23.3M
Current Liabilities	EUR 4M
Debt	EUR 9.4M
Debt EBITDA	EUR 2.46
Debt Equity	EUR 0.49
Debt FCF	EUR 25.12
Equity	EUR 19.4M
Interest Coverage	4.51
Liabilities	EUR 13M
Long Term Assets	EUR 9.1M
Long Term Liabilities	EUR 9M
Net Cash	EUR -401,442
Net Cash By Market Cap	EUR -3.55
Net Debt EBITDA	EUR 0.12
Net Debt Equity	EUR 0.02
Net Debt FCF	EUR 1.07
Tangible Book Value	EUR 19.1M
Tangible Book Value Per Share	EUR 4.31
WACC	5.63

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.75
Inventory Turnover	1.76
Net Working Capital	EUR 11.1M
Quick ratio	4.97
Working Capital	EUR 19.2M
Working Capital Turnover	EUR 1.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	116.67%
Dividend Growth Years	1%
Dividend per share	EUR 0.13
Dividend Years	3
Dividend Yield	5.08%
Ex Div Date	2025-07-04
Last Dividend	EUR 0.13
Payout Frequency	Annual
Payout Ratio	13.98%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	422.11%
1Y total return	21.43%
200-day SMA	2.53
3Y total return	-24.72%
50-day SMA	2.46
50-day SMA vs 200-day SMA	50under200
5Y total return	38.56%
All Time High	9.82
All Time High Change	-73.92%
All Time High Date	2001-12-12
All Time Low	0.22
All Time Low Change	1,062.05%
All Time Low Date	2015-03-04
ATR	0.06
Beta	0.45
Beta1y	0.6
Beta2y	0.5
Ch YTD	1.19
High	2.57
High52	2.92
High52 Date	2025-08-14
High52ch	-12.33%
Low	2.5
Low52	2.14
Low52 Date	2025-05-09
Low52ch	19.63%
Ma50ch	3.94%
Price vs 200-day SMA	1.23%
RSI	59.41
RSI Monthly	49.28
RSI Weekly	54.67
Sharpe ratio	0.78x
Sortino ratio	1.47
Total Return	5.08%
Tr YTD	1.19
Tr15y	43.53%
Tr1m	3.23%
Tr1w	2.4%
Tr3m	-2.29%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 2.2M
Operating Income Growth	34.73
Operating Income Growth Q	173.6
Operating Income Growth3 Y	7.64
Operating Income Growth5 Y	-10.39
Operating margin	11.99

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	-805,564
Shares Out	4,419,616
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 374,744
Average Volume	3,012.45x
Bv Per Share	4.32
CAPEX	EUR -789,211
Ch10y	363.8
Ch15y	14.8
Ch1m	3.23
Ch1w	2.4
Ch1y	14.8
Ch20y	-42.6
Ch3m	-2.29
Ch3y	-31.18
Ch5y	23.08
Ch6m	2.4
Change	-0.78%
Change From Open	-0.39
Close	2.58
Days Gap	-0.39
Depreciation Amortization	1,219,655
Dollar Volume	5,913.6
Earnings Date	2026-04-30
EBIT	EUR 2.2M
EBITDA	EUR 3.4M
EPS	EUR 0.43
F Score	5
FCF	EUR 374,744
FCF EV Yield	3.13x
FCF Per Share	EUR 0.08
Financing CF	-1,067,905
Fiscal Year End	December
Founded	1,988
Graham Number	6.46153
Graham Upside	152.4
Income Tax	EUR 378,133
Investing CF	-99,271
Is Primary Listing	1
Last Earnings Date	2026-04-30
Last Report Date	2025-06-30
Last Split Date	2004-07-28
Last Split Type	Forward
Lynch Fair Value	EUR 2.15
Lynch Upside	-16.15
Ma150	2.53
Ma150ch	1.07%
Ma20	2.48
Ma20ch	3.35%
Net CF	-3,221
Next Earnings Date	2026-09-30
Open	2.57
P FCF Ratio	30.19
P OCF Ratio	9.72
Payment Date	2025-07-11
Position In Range	85.71
Ppne	6,314,358
Price Date	2026-05-08
Price EBITDA	EUR 3.29
Ptbv Ratio	0.59
Relative Volume	0.77x
Revenue	18,540,107x
Tax By Revenue	2.04x
Tax Rate	17.37%
Tr20y	6.12%
Tr6m	2.4%
Volume	2,310
Z Score	2.5

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ATH/MEDIC dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.1%

$0.13 annual per share

Payout ratio

+14.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+2.8%

1 consecutive years of growth

Total shareholder yield

+5.1%

Next ex-dividend date: 2025-07-04

Performance

ATH/MEDIC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Technical

ATH/MEDIC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.4

Neutral momentum band

Price vs 200-day MA

+1.2%

50/200-day relationship not available

Beta (5Y)

0.45

Less volatile than the market

Sharpe ratio

0.78

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ATH/MEDIC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ath/MEDIC stock rating?

ath/MEDIC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ath/MEDIC analysis?

The full report lives at /stocks/ath/MEDIC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ath/MEDIC?

The latest report frames ath/MEDIC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ath/MEDIC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.